BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31165977)

  • 1. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs).
    Behzadi P
    Folia Microbiol (Praha); 2020 Feb; 65(1):45-65. PubMed ID: 31165977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes.
    Zamani H; Salehzadeh A
    Turk J Med Sci; 2018 Feb; 48(1):162-167. PubMed ID: 29479978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Regulation of the Diguanylate Cyclase YaiC Reduces Production of Type 1 Fimbriae in a Pst Mutant of Uropathogenic Escherichia coli CFT073.
    Crépin S; Porcheron G; Houle S; Harel J; Dozois CM
    J Bacteriol; 2017 Dec; 199(24):. PubMed ID: 28924030
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bessaiah H; Pokharel P; Habouria H; Houle S; Dozois CM
    Front Cell Infect Microbiol; 2019; 9():312. PubMed ID: 31555608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of antigen Ag43 in uropathogenic Escherichia coli Dr+ strains and defining its role in the pathogenesis of urinary tract infections.
    Zalewska-Pia Tek B; Pia Tek R; Olszewski M; Kur J
    Microbiology (Reading); 2015 May; 161(Pt 5):1034-1049. PubMed ID: 25743156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells.
    Wurpel DJ; Totsika M; Allsopp LP; Webb RI; Moriel DG; Schembri MA
    J Proteomics; 2016 Jan; 131():177-189. PubMed ID: 26546558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.
    Floyd KA; Mitchell CA; Eberly AR; Colling SJ; Zhang EW; DePas W; Chapman MR; Conover M; Rogers BR; Hultgren SJ; Hadjifrangiskou M
    J Bacteriol; 2016 Oct; 198(19):2662-72. PubMed ID: 27161114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
    Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
    Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Remarkable Biomechanical Properties of the Type 1 Chaperone-Usher Pilus: A Structural and Molecular Perspective.
    Hospenthal MK; Waksman G
    Microbiol Spectr; 2019 Jan; 7(1):. PubMed ID: 30681068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Galβ1-3GlcNAc-containing glycans.
    Wurpel DJ; Totsika M; Allsopp LP; Hartley-Tassell LE; Day CJ; Peters KM; Sarkar S; Ulett GC; Yang J; Tiralongo J; Strugnell RA; Jennings MP; Schembri MA
    PLoS One; 2014; 9(3):e93177. PubMed ID: 24671091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of New Genes Involved in Curli Production by a Uropathogenic Escherichia coli Strain from the Highly Virulent O45:K1:H7 Lineage.
    Nhu NTK; Phan MD; Peters KM; Lo AW; Forde BM; Min Chong T; Yin WF; Chan KG; Chromek M; Brauner A; Chapman MR; Beatson SA; Schembri MA
    mBio; 2018 Aug; 9(4):. PubMed ID: 30131362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli.
    Battaglioli EJ; Goh KGK; Atruktsang TS; Schwartz K; Schembri MA; Welch RA
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087170
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
    Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.
    Spaulding CN; Klein RD; Ruer S; Kau AL; Schreiber HL; Cusumano ZT; Dodson KW; Pinkner JS; Fremont DH; Janetka JW; Remaut H; Gordon JI; Hultgren SJ
    Nature; 2017 Jun; 546(7659):528-532. PubMed ID: 28614296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.
    Crépin S; Houle S; Charbonneau MÈ; Mourez M; Harel J; Dozois CM
    Infect Immun; 2012 Aug; 80(8):2802-15. PubMed ID: 22665376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection.
    Buckles EL; Luterbach CL; Wang X; Lockatell CV; Johnson DE; Mobley HL; Donnenberg MS
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25673667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
    J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.